Daytime sleepiness, agonist therapy, and driving in Parkinson disease

JAMA

Volumn 287, Issue 4, 2002, Pages 509-511

  Comella, Cynthia L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PRAMIPEXOLE; ROPINIROLE;

DRUG EFFECT; EDITORIAL; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; SOMNOLENCE; TREATMENT OUTCOME;

EID: 0037160553     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.4.509     Document Type: Editorial

References (29)

1. Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole
2. Antiparkinsonian drugs and "sleep attacks"
3. Parkinson'disease and the ability to drive
4. Non-ergot dopamine agonist-induced sleep attacks
5. Pramipexole-induced somnolence and episodes of daytime sleep
6. Sleep attacks (sleep episodes) with pergolide
7. Sleep attacks and Parkinson'disease treatment
8. Modification of parkinsonism-chronic treatment with L-dopa
9. L-dopa therapy in Parkinson's disease: A critical review of nine years' experience
10. Effects of levodopa in parkinsonian patients with dementia
11. Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy
12. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: A survey by the Canadian Movement Disorders Group
13. A community-based study of sleep disorders patients with Parkinson's disease
14. Sleep and Parkinson's disease
15. Assessment and treatment of sleep disturbances in older adults
16. Efficacy of pramipexole, a novel dopamine agonist, as monotherpay in mild to moderate Parkinson's disease
17. Ropinirole for the treament of early Parkinson's disease
18. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial
19. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
20. Dopamine agonists in early therapy for Parkinson disease: Promise and problems
21. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and comnination therapy
22. Daytime sleepiness and other sleep disorders in Parkinson's disease
23. Guidelines for the multiple sleep latency test (MSLT): A standard measure of sleepiness
24. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale
25. Reliability and factor analysis of the Epworth Sleepiness Scale
26. Association between the Epworth Sleepiness Scale and the Multiple Sleep Latency Test in a clinical population
27. The Epworth Sleepiness Scale may not reflect objective measures of sleepiness or sleep apnea
28. Relationship between sleepiness and general health status
29. Daytime sleepiness in Parkinson's disease